China Healthcare Summit
November 2-3, 2023 | Shanghai

November 7-8, 2023 | Digital

BioCentury and BayHelix’s China Healthcare Summit marks its 10th Anniversary with a return to Shanghai, gathering C-level executives from Asia and beyond for renewed cross-border collaboration and discussion. Innovation from Asian biotechs is on the rise, presenting new opportunities for partnership and investment. China Summit is specifically tailored for C-level executives and VCs, with a strategic program offering a first-hand look at the innovation, business, and policy transformations taking place in China and Asia. Don’t miss this opportunity to join your peers in-person in Shanghai Nov. 2-3, and for an additional 2 days of virtual meetings from Nov. 7-8, to explore transformative opportunities with global reach.

---

Written by Richard Daverman, PhD. Click a link below to view the mailing archive as if it had been sent to you. 2013-06-30 01:30 Week in Review: Simcere Raises $65 Million by Selling Boda Subsidiary and more... 2013-06-29 01:30 Fosun Named One of China's Top Ten Innovative Pharmas 2013-06-28 01:30 Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine and more... 2013-06-27 01:30 Thermo Fisher Invests $9.5 Million in China Innovation Center and more... 2013-06-26 01:30 Biohit Forms China JV for Diagnostic Test and more... 2013-06-25 01:30 Simcere Raises $65 Million by Selling its Boda Pharma Subsidiary 2013-06-23 01:30 Week in Review: Zhejiang Medicine to Develop Ambrx Breast Cancer Drug 2013-06-22 01:30 China Talks to Johnson & Johnson about its Product Recalls and more... 2013-06-21 01:30 BioClinica Partners with TEDA Cardiovascular Hospital 2013-06-20 01:30 Suzhou Ribo Licenses siRNA Delivery System from Life Techologies 2013-06-19 01:30 BoXin LaiTe Biotechnology and University of British Columbia Sign MOU 2013-06-16 01:30 Week in Review: Mindray Medical Buys US Ultrasound Company for $105 Million 2013-06-15 01:30 Simcere Announces Third Drug Development Partnership with BMS 2013-06-14 01:30 Mindray Buys Zonare, a US Ultrasound Company, for $105 Million 2013-06-13 01:30 GSK Fires China R&D Chief for Misrepresenting Data 2013-06-12 01:30 Alliance Boots Looking for China M&A and more... 2013-06-11 01:30 Chia-tai Tianqing Pharma Gains China Rights for Hepatitis C Drug from BioLineRx 2013-06-09 01:30 Week in Review: Boehringer Ingelheim to Build Biopharma CMO in Shanghai 2013-06-08 01:30 China's CDCP and Columbia University Join to Form Pathogen Lab in Beijing 2013-06-07 01:30 Boehringer Ingelheim to Build cGMP Biopharma Facility in Shanghai and more... 2013-06-06 01:30 CSRC Terminates IPO Applications of 15 China Life Science Companies 2013-06-05 01:30 Over 750 Life Science Executives Met Potential Partners at ChinaBioÔö£éÔö¼?½ Partnering Forum 2013 in Beijing and more... 2013-06-04 01:30 Genor Biopharma and BioCND to Co-Develop Two Popular Biosimilars 2013-06-02 01:30 Week in Review: BeiGene Sells Novel Cancer Drug to Merck Serono 2013-06-01 01:30 BeiGene Licenses Ex-China Rights for Cancer Molecule to Merck Serono and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz Not a ChinaBio®Today Subscriber? Here's what you get with a paid subscription to ChinaBio® Today: Website access to all current articles and commentary Full access to over 2000 archived articles on the biotech industry Get started now for as little as $20... ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC